Form 4 for CDT CDT Equity Inc.
Accepted 2023-09-26 00:00:00 ET · period of report 2023-09-22 · accession 0001493152-23-033793 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-26 | 2023-09-22 | CDT | Farley Chele Chiavacci | Dir | A - Grant | — | +15.0K | 15.0K | New | — |
| D | 2023-09-26 | 2023-09-22 | CDT | Farley Chele Chiavacci | Dir | A - Grant | $11.50 | +15.0K | 15.0K | New | +$172.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share ("Shares") | 2023-09-22 | A | A | 15,000 | — | 15,000 | D | — | — | (F1) Includes 15,000 shares of common stock of the Company and 15,000 redeemable warrants that Murphy Canyon Acquisition Sponsor, LLC transferred to Ms. Farley in consideration for her acting as an independent director of the Company. Such Shares and warrants were transferred to Mr. Farley immediately after the closing of the business combination contemplated by the Agreement and Plan of Merger, dated as of November 8, 2022 and as amended on January 27, 2023 and May 11, 2023 (the "Merger Agreement"), by and among the Company, Conduit Pharmaceuticals Limited, a Cayman Islands exempted company ("Conduit") and Conduit Merger Sub, Inc., a Cayman Islands exempted company and a wholly-owned subsidiary of MURF (the "Merger Sub"). As a result of, and upon consummation of the transactions contemplated by, the Merger Agreement, the Company changed its name from "Murphy Canyon Acquisition Corp." to "Conduit Pharmaceuticals Inc." |
| 2 | Derivative | Warrants | 2023-09-22 | A | A | 15,000 | $11.50 | 15,000 | D | $11.50 · — to 2028-10-22 | 15,000 Shares | (F2) The redeemable warrants become exercisable 30 days after the completion of the business combination contemplated by the Merger Agreement, which occurred on September 22, 2023. Accordingly, the redeemable warrants become exercisable on October 22, 2023 and expire on October 22, 2028. |